Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor - Kubitza, D; Becka, M; Mueck, W (Br J Clin Pharmacol, 2010)
, et al.